PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/3474/2/21
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Britannia
Ever Pharma complained that Britannia Pharmaceuticals Ltd used an 0844 business-rate telephone number for calls about services and patient information related to APO-go (apomorphine).Ever Pharma al…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3463/1/21
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck corporate website
An anonymous, contactable complainant (self-described health professional) challenged content on Lundbeck Limited’s UK corporate website, including the homepage and an R&D page.The homepage i…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3464/1/21
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Novartis breached ABPI Code after edited Beovu HCP video omitted safety caution (AUTH/3464/1/21)
A healthcare practitioner complained about a Novartis promotional Beovu (brolucizumab) website hosting an edited HCP video titled ‘First experience in [country]: Patient cases and implementation�…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3465/2/21
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor
An anonymous, contactable complainant (a concerned UK health professional) alleged Vifor Pharma UK Limited used the PIVOTAL study to promote off-licence use of Venofer (iron sucrose IV).The complai…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3466/2/21
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck corporate website
An anonymous, contactable complainant (self-described health professional) complained about Lundbeck Limited’s UK corporate website and referenced a prior complaint about similar material (Case A…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3475/2/21
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Lundbeck
An anonymous, contactable complainant (health professional) raised concerns about alleged promotion of Vyepti (eptinezumab), which did not have a UK marketing authorisation at the time.The complain…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3478/2/21
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Boehringer Ingelheim
An anonymous complainant (self-described health professional) alleged Boehringer Ingelheim employees’ LinkedIn activity was unethical and promoted an unlicensed medicine to health professionals a…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3545/7/21
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached Clause 5.1 after listing an 0845 number for side-effect reporting on Saxenda p
A UK health professional complained that the Saxenda (liraglutide) patient website (www.saxenda.co.uk) listed an 0845 telephone number under “Reporting of side effects” for reporting adverse ev…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3458/1/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Napp
An anonymous, contactable UK health professional complained about Napp’s promotion of Invokana (canagliflozin).The material was an on-demand promotional video hosted on Diabetes On The Net: “CR…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3479/2/21
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Almirall
A health professional complained about a LinkedIn post that appeared in their feed, originally posted by Almirall’s Spanish head office and ‘liked’ by a senior UK employee.The post stated “…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3488/3/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca breached Code over Trixeo website mobile display and missing comparator prescribing info
An anonymous complainant challenged AstraZeneca’s UK promotional website for Trixeo Aerosphere (www.trixeo.co.uk) and a downloadable Trixeo formulary pack.Allegations included: public access (no …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3496/3/21
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
AbbVie breached ABPI Code over Skyrizi banner implying BAD guidelines specifically recommended it fi
A health professional complained about a digital banner ad for Skyrizi (risankizumab) placed by AbbVie on the British Dermatological Nursing Group website.The banner headline stated: “BAD [Britis…
Clauses: 9.1,3.2
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3476/2/21
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Leo Pharma
A contactable complainant challenged statements on a named Leo Pharma medical department employee’s publicly viewable LinkedIn profile (open privacy settings alleged), including claimed qualifica…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3498/3/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
LEO Pharma
An anonymous, contactable ex-employee complained about LEO Pharma UK/IE’s public disclosures of support to patient organisations (company website list and Disclosure UK).The complaint focused on …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3477/2/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca Symbicort Turbu+ package deal
An anonymous, non-contactable complainant (described as a respiratory nurse) complained about AstraZeneca UK’s Symbicort Turbohaler (budesonide/formoterol) “Turbu+” package deal and the Turbu…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3480/3/21
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
GSK breach of
A complainant (self-described concerned healthcare professional) cited a third-party LinkedIn post reviewing four historic GSK cases (AUTH/2787/8/15, AUTH/3148/1/19, AUTH/3328/4/20, AUTH/3341/5/20)…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3452/1/21
Social Media & Digital Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
An anonymous health professional complained about a webpage on Lundbeck UK’s gated “Progress in Mind” Psychiatry and Neurology resource centre.A Lundbeck MSL had directed the complainant to t…
Clauses: 9.1,4.3,26.1
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3515/5/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK webinar registration implied COPD medicines were licensed for asthma; Clause 2 upheld on appeal
An anonymous health professional complained about two items promoting Seretide (fluticasone/salmeterol) by GlaxoSmithKline UK Limited (GSK).Item A (webinar registration page): An online registratio…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3499/4/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo website page promoted Efient and Lixiana to the public and breached a prior undertaki
An anonymous complainant alleged Daiichi-Sankyo promoted prescription-only medicines (Efient/prasugrel and Lixiana/edoxaban) to the public via a corporate website page.The page included brand and g…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3506/4/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
A complainant (later non-contactable) challenged a two-page hard-copy journal advertisement for Lixiana (edoxaban) in Guidelines in Practice (March 2021, Vol 24, Issue 3).The ad (job code EDX/20/11…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3504/4/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
A complainant raised concerns about multiple webpages on Daiichi-Sankyo UK’s HCP website promoting Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe) (Job Code BEM/20/0242; prepared…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3451/1/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Teva respiratory websites
An anonymous (initially contactable) health professional complained about two Teva-owned sites: the Teva UK corporate site (HCP respiratory section) and the “Let’s Talk Respiratory” (LTR) web…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3507/5/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
An anonymous complainant raised two related complaints about promotion of Lixiana (edoxaban) linked to a sponsored symposium: “Anticoagulation in stroke prevention: Optimising clinical and medici…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3497/3/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous complainant challenged content on two Daiichi Sankyo websites relating to Lixiana (edoxaban): an HCP site (lixiana-hcp.co.uk) and a patient-directed site (myanticoagulant.co.uk).Multip…
Clauses: NONE
2021 🔒 Subscribe
← Prev 7 8 9 10 11 12 13 Next → Page 10 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews